PT  - JOURNAL ARTICLE
AU  - Adhiambo, Harriet Fridah
AU  - Lewis-Kulzer, Jayne
AU  - Nyagesoa, Edwin
AU  - Gimbel, Sarah
AU  - Akama, Eliud
AU  - Mangale, Dorothy
AU  - Montonya, Lina
AU  - Eshun-Wilson, Ingrid
AU  - Iguna, Sarah
AU  - Nyandieka, Everlyne
AU  - Bukusi, Elizabeth
AU  - Abuogi, Lisa
AU  - Odeny, Thomas
AU  - Petersen, Maya L.
AU  - Geng, Elvin H.
TI  - Examining and classifying reasons for missing viral loads among adults living with HIV: An extended outcome investigation and ascertainment approach in Western Kenya
AID  - 10.1101/2024.11.22.24317791
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.11.22.24317791
4099  - http://medrxiv.org/content/early/2024/11/23/2024.11.22.24317791.short
4100  - http://medrxiv.org/content/early/2024/11/23/2024.11.22.24317791.full
AB  - Introduction Gaps in HIV RNA monitoring persist globally impeding the ability to determine clinical progress and outcomes. This study systematically evaluated provider (e.g., guideline non- adherence), system (e.g., laboratory error) and patient-based (e.g., refusal) drivers of missed viral load (VL) monitoring measurements among adults living with HIV in Kenya.Methods Adults aged 18-65 years were followed across five health facilities in Kenya as part of a clinical trial (NCT#02338739) where HIV RNA monitoring was done routinely. Instances of missed VL despite being indicated per Kenyan guidelines were identified. An algorithm for assessing root causes of missing HIV RNA was developed and generalized linear models estimated the risk ratios (RR) for patient-level characteristics associated with missed viral load.Results Among 1,754 patients (66% female), the prevalence of missed viral load in year one and two was 24.4% and 29.4%, respectively. Drivers for missed viral load measurements included loss to follow up (51.5% in year one and 57.8% in year two), clinician non-adherence with guidelines (36.7% in year one and 32.2% in year two), unknown (10.3% in year one and 8.6% in year two), and requested but not collected (1.5% in year one and 1.3% in year two). Patients aged < 24 years (RR 2.27, 95% CI: 1.66-3.12), those with higher socioeconomic status (RR 1.47, 95% CI: 1.03- 1.91), receiving HIV treatment at a rural clinic (RR 1.22, 95% CI: 1.02-1.46) and with advanced HIV disease (RR 2.39, 95% CI: 1.52-3.73) were more likely to miss VL monitoring.Conclusions Missed routine viral load monitoring remains high, primarily due to loss to follow- up, and may substantially alter suppression estimates. Sustainable approaches to keep people living with HIV engaged in care, alongside strengthening providers’ clinical practices and alignment with national guidelines, are necessary for optimizing viral monitoring and accurately assessing viral suppression within public health systems.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT#02338739Funding StatementThis work was supported by 2 grants from the National Institutes of Nursing Research (NCT02338739 and K24 AI134413 awarded to EG) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Kenya Medical Research Institute and the the IRB at Washington University in St LouisI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData will be available upon request made to the corresponding author